Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, and Chronic Myeloid Leukemia Treatments.
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Outcomes of COVID-19 in patients with CLL: a multicenter international experience